Oruka Therapeutics Inc (ORKA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2003 | 03-2003 | 12-2002 | 09-2002 | 06-2002 | |
| Cash Flows From Operating Activities | |||||
| Net Income | N/A | N/A | -44,978 | N/A | N/A |
| Depreciation Amortization | N/A | N/A | 6,247 | N/A | N/A |
| Accounts receivable | N/A | N/A | 303 | N/A | N/A |
| Accounts payable and accrued liabilities | N/A | N/A | -2,585 | N/A | N/A |
| Other Working Capital | N/A | N/A | 22,938 | N/A | N/A |
| Other Operating Activity | -24,379 | -10,567 | -12,833 | -23,510 | -16,277 |
| Operating Cash Flow | $-24,379 | $-10,567 | $-30,908 | $-23,510 | $-16,277 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 17,536 | 7,580 | N/A | N/A | N/A |
| PPE Investments | -124 | -173 | -2,001 | -1,812 | -1,592 |
| Net Acquisitions | 25,715 | 25,715 | N/A | N/A | N/A |
| Investing Cash Flow | $43,127 | $33,122 | $-2,001 | $-1,812 | $-1,592 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 1,000 | 1,000 | 10,000 | 4,000 | 4,000 |
| Debt Repayment | -1,175 | -553 | -2,491 | -1,935 | -1,279 |
| Common Stock Issued | 500 | 59 | 14,796 | 14,700 | 14,653 |
| Other Financing Activity | -756 | 0 | 500 | 500 | 0 |
| Financing Cash Flow | $-431 | $506 | $22,805 | $17,265 | $17,374 |
| Beginning Cash Position | 2,225 | 2,225 | 12,329 | 12,329 | 12,329 |
| End Cash Position | 20,542 | 25,286 | 2,225 | 4,272 | 11,834 |
| Net Cash Flow | $18,317 | $23,061 | $-10,104 | $-8,057 | $-495 |
| Free Cash Flow | |||||
| Operating Cash Flow | -24,379 | -10,567 | -30,908 | -23,510 | -16,277 |
| Capital Expenditure | -202 | -226 | -2,063 | -1,865 | -1,630 |
| Free Cash Flow | -24,581 | -10,793 | -32,971 | -25,375 | -17,907 |